Skip to main content
Erschienen in: Neurological Sciences 3/2019

01.03.2019 | Original Article

Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up

verfasst von: Enrico Granieri, Nico Golfrè Andreasi, Paolo De Martin, Vittorio Govoni, Massimiliano Castellazzi, Edward Cesnik, Maura Pugliatti, Ilaria Casetta

Erschienen in: Neurological Sciences | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Guillain-Barré syndrome (GBS) is an acute/subacute autoimmune inflammatory polyradiculoneuropathy. Previous epidemiological studies carried out in the province of Ferrara, Italy, from 1981 to 2002 indicated that GBS incidence had tendency of increase in the period considered.

Objectives

We aimed at updating the epidemiology of GBS in the years 2003–2017 and carrying on the work started in the 1980s.

Methods

We conducted an incidence study, by adopting a complete enumeration approach. Cases were identified from administrative, medical records, and database of the Ferrara Hospital and other provincial structures of the study area. Case ascertainment and definition are analogous to those adopted in previous surveys.

Results

In the period 1 January 2003 to 31 December 2017, 73 patients living in the province of Ferrara (mean population 353,142) were found to be new cases of GBS fulfilling the NINCDS criteria. Male/female ratio 1.15. The mean incidence rate was 1.38 per 100,000 (95% CI 1.08–1.74), 1.54 per 100,000 for men and 1.23 per 100,000 for women, a nonsignificant difference. During the period considered, the rates had slow increase or mild decrease, without nonsignificant difference. The highest rates were observed for the age groups 70–79 years for both sexes. A half of patients reported infectious events in the weeks before the onset of symptoms.

Conclusion

In line with many epidemiological data, in the whole period 2003–2017, we observed a trend towards increase or decrease in incidence and periods of relative stability. Similar temporal heterogeneity with the comparison to our previous works was found.
Literatur
2.
Zurück zum Zitat Hardy TA, Blum S, McCombe PA, Reddel SW (2011) Guillain-Barré syndrome: modern theories of etiology. Curr Allergy Asthma Rep 11:197–204CrossRefPubMed Hardy TA, Blum S, McCombe PA, Reddel SW (2011) Guillain-Barré syndrome: modern theories of etiology. Curr Allergy Asthma Rep 11:197–204CrossRefPubMed
4.
Zurück zum Zitat Fujimura H (2013) The Guillain-Barré syndrome. In Said G, Krarup C (eds): Peripheral nerve disorders. In Aminoff MJ, Boller F, Swaab D (series eds): Handbook of clinical neurology Edinburgh London New York Oxford Philadelphia St Louis Sidney Toronto, Elsevier BV, vol 115 (3rd series), 383-402 Fujimura H (2013) The Guillain-Barré syndrome. In Said G, Krarup C (eds): Peripheral nerve disorders. In Aminoff MJ, Boller F, Swaab D (series eds): Handbook of clinical neurology Edinburgh London New York Oxford Philadelphia St Louis Sidney Toronto, Elsevier BV, vol 115 (3rd series), 383-402
5.
Zurück zum Zitat Olivé JM, Castillo C, Garcia Castro R, de Quadros CA (1997) Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. J Infect Dis 175:160–164CrossRef Olivé JM, Castillo C, Garcia Castro R, de Quadros CA (1997) Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. J Infect Dis 175:160–164CrossRef
6.
Zurück zum Zitat Govoni V, Granieri E (2001) Epidemiology of Guillain-Barré syndrome. Curr Op Neurol 14:605–613CrossRef Govoni V, Granieri E (2001) Epidemiology of Guillain-Barré syndrome. Curr Op Neurol 14:605–613CrossRef
7.
Zurück zum Zitat Paolino E, Govoni V, Tola MR, Casetta I, Granieri E (1991) Incidence of the Guillain-Barré syndrome in Ferrara, Northern Italy, 1981–1987. Neuroepidemiology 10:105–111CrossRefPubMed Paolino E, Govoni V, Tola MR, Casetta I, Granieri E (1991) Incidence of the Guillain-Barré syndrome in Ferrara, Northern Italy, 1981–1987. Neuroepidemiology 10:105–111CrossRefPubMed
8.
Zurück zum Zitat Govoni V, Granieri E, Casetta I, Tola MR, Paolino E, Fainardi E, Monetti VC (1996) The incidence of Guillain-Barré syndrome in Ferrara, Italy: is the disease really increasing? J Neurol Sci 137:62–68CrossRefPubMed Govoni V, Granieri E, Casetta I, Tola MR, Paolino E, Fainardi E, Monetti VC (1996) The incidence of Guillain-Barré syndrome in Ferrara, Italy: is the disease really increasing? J Neurol Sci 137:62–68CrossRefPubMed
9.
Zurück zum Zitat Govoni V, Granieri G, Manconi M, Capone J, Casetta I (2003) Is there a decrease in Guillain–Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. J Neurol Sci 15(216):99–103CrossRef Govoni V, Granieri G, Manconi M, Capone J, Casetta I (2003) Is there a decrease in Guillain–Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. J Neurol Sci 15(216):99–103CrossRef
10.
Zurück zum Zitat Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27(Suppl):S21–S24CrossRefPubMed Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27(Suppl):S21–S24CrossRefPubMed
12.
Zurück zum Zitat Waterhouse JAH, Muir CS, Correa P, Powell J (1976) Cancer incidence in five continents. Lyon, IARC 3: 456 Waterhouse JAH, Muir CS, Correa P, Powell J (1976) Cancer incidence in five continents. Lyon, IARC 3: 456
13.
Zurück zum Zitat Schoenberg BS (1983) Calculating confidence intervals for rates and ratios: simplified methods utilizing tabular values based in the Poisson distribution. Neuroepidemiology 2:257–265CrossRef Schoenberg BS (1983) Calculating confidence intervals for rates and ratios: simplified methods utilizing tabular values based in the Poisson distribution. Neuroepidemiology 2:257–265CrossRef
14.
Zurück zum Zitat Benedetti MD, Pugliatti M, D’ Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Galeotti F, Massari M, Santuccio C, Raschetti R, ITANG Study Group (2015) A multicentric prospective incidence study of Guillain-Barré syndrome in Italy. The ITANG Study. Neuroepidemiology 45:90–99CrossRefPubMed Benedetti MD, Pugliatti M, D’ Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Galeotti F, Massari M, Santuccio C, Raschetti R, ITANG Study Group (2015) A multicentric prospective incidence study of Guillain-Barré syndrome in Italy. The ITANG Study. Neuroepidemiology 45:90–99CrossRefPubMed
15.
Zurück zum Zitat Cuadrado JI, de Pedro-Cuesta J, Ara JR, Cemillán CA, Díaz M, Duarte J, Fernández MD, Fernandez O, García-López F, García-Merino A, Velasquez JM, Martínez-Matos JA, Palomo F, Pardo J, Tobías A for the Spanish GBS Epidemiological Study Group (2004) Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurol Sci 25:57–65CrossRefPubMed Cuadrado JI, de Pedro-Cuesta J, Ara JR, Cemillán CA, Díaz M, Duarte J, Fernández MD, Fernandez O, García-López F, García-Merino A, Velasquez JM, Martínez-Matos JA, Palomo F, Pardo J, Tobías A for the Spanish GBS Epidemiological Study Group (2004) Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurol Sci 25:57–65CrossRefPubMed
16.
Zurück zum Zitat Mc Grogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain-Barré syndrome worldwide: a systemic literature review. Neuroepidemiology 32:150–163CrossRef Mc Grogan A, Madle GC, Seaman HE, de Vries CS (2009) The epidemiology of Guillain-Barré syndrome worldwide: a systemic literature review. Neuroepidemiology 32:150–163CrossRef
17.
Zurück zum Zitat Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 36:123–133CrossRefPubMedPubMedCentral Sejvar JJ, Baughman AL, Wise M, Morgan OW (2011) Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 36:123–133CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Hense S, Schink T, Kreisel SH, Marcelon L, Simondon F, Tahden M, Garbe E (2014) Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data. Neuroepidemiology 43:244–252CrossRefPubMed Hense S, Schink T, Kreisel SH, Marcelon L, Simondon F, Tahden M, Garbe E (2014) Estimation of background incidence rates of Guillain-Barré syndrome in Germany - a retrospective cohort study with electronic healthcare data. Neuroepidemiology 43:244–252CrossRefPubMed
19.
Zurück zum Zitat Delannoy A, Rudant J, Chaignot C, Bolgert F, Mikaeloff Y, Weill A (2017) Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013). J Peripher Nerv Syst 22:51–58CrossRefPubMed Delannoy A, Rudant J, Chaignot C, Bolgert F, Mikaeloff Y, Weill A (2017) Guillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013). J Peripher Nerv Syst 22:51–58CrossRefPubMed
20.
Zurück zum Zitat Cheng Q, Jiang GX, Fredrikson S, Link H, De Pedro-Cuesta J (2000) Incidence of Guillain-Barré syndrome in Sweden 1996. Eur J Neurol 7:11–16CrossRefPubMed Cheng Q, Jiang GX, Fredrikson S, Link H, De Pedro-Cuesta J (2000) Incidence of Guillain-Barré syndrome in Sweden 1996. Eur J Neurol 7:11–16CrossRefPubMed
21.
Zurück zum Zitat Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meché FG (2000) Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620–625CrossRefPubMed Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meché FG (2000) Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54:620–625CrossRefPubMed
22.
Zurück zum Zitat Aladro-Benito Y, Conde-Sendin MA, Muñoz-Fernández C, Pérez-Correa S, Alemany-Rodríguez MJ, Fiuza-Pérez MD, Alamo-Santana F (2002) Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote. Rev Neurol 35:705–710PubMed Aladro-Benito Y, Conde-Sendin MA, Muñoz-Fernández C, Pérez-Correa S, Alemany-Rodríguez MJ, Fiuza-Pérez MD, Alamo-Santana F (2002) Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote. Rev Neurol 35:705–710PubMed
23.
Zurück zum Zitat Huges RA, Charlton J, Latinovic R, Gulliford MC (2006) No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 166:1301–1304CrossRef Huges RA, Charlton J, Latinovic R, Gulliford MC (2006) No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 166:1301–1304CrossRef
24.
Zurück zum Zitat Sipilä JOT, Soilu-Hänninen M, Ruuskanen JO, Rautava P, Kytö V (2017) Epidemiology of Guillain-Barré syndrome in Finland 2004–2014. J Peripher Nerv Syst 22:440–445CrossRefPubMedPubMedCentral Sipilä JOT, Soilu-Hänninen M, Ruuskanen JO, Rautava P, Kytö V (2017) Epidemiology of Guillain-Barré syndrome in Finland 2004–2014. J Peripher Nerv Syst 22:440–445CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL (1991) The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome. Ann Neurol 30:618–621CrossRefPubMed Koobatian TJ, Birkhead GS, Schramm MM, Vogt RL (1991) The use of hospital discharge data for public health surveillance of Guillain-Barré syndrome. Ann Neurol 30:618–621CrossRefPubMed
26.
Zurück zum Zitat Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, Ho D, Lee GM, Yih WK, Vaccine Safety Datalink Research Team (2012) Guillain-Barré syndrome incidence in a large United States cohort (2000–2009). Neuroepidemiology 39:109–115CrossRefPubMed Shui IM, Rett MD, Weintraub E, Marcy M, Amato AA, Sheikh SI, Ho D, Lee GM, Yih WK, Vaccine Safety Datalink Research Team (2012) Guillain-Barré syndrome incidence in a large United States cohort (2000–2009). Neuroepidemiology 39:109–115CrossRefPubMed
27.
Zurück zum Zitat Blum S, Reddel S, Spies J, McCombe P (2013) Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia. J Peripher Nerv Syst 18:316–320CrossRefPubMed Blum S, Reddel S, Spies J, McCombe P (2013) Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia. J Peripher Nerv Syst 18:316–320CrossRefPubMed
28.
Zurück zum Zitat Chen Y, Ma F, Zhang J, Chu X, Hu Y (2014) Population incidence of Guillain-Barré syndrome in parts of China: three large populations in Jiangsu province, 2008–2010. Eur J Neurol 21:124–129CrossRefPubMed Chen Y, Ma F, Zhang J, Chu X, Hu Y (2014) Population incidence of Guillain-Barré syndrome in parts of China: three large populations in Jiangsu province, 2008–2010. Eur J Neurol 21:124–129CrossRefPubMed
29.
Zurück zum Zitat Yoshikawa H (2015) Epidemiology of Guillain-Barré syndrome. Brain Nerve 67:1305–1311PubMed Yoshikawa H (2015) Epidemiology of Guillain-Barré syndrome. Brain Nerve 67:1305–1311PubMed
30.
Zurück zum Zitat Alcalde-Cabero E, Almazán-Isla J, García López FJ, Ara-Callizo JR, Avellanal F, Casasnovas C, Cemillán C, Cuadrado JI, Duarte J, Fernández-Pérez MD, Fernández Ó, Merino JA, Montero RG, Montero D, Pardo J, Rodríguez-Rivera FJ, Ruiz-Tovar M, de Pedro-Cuesta J; Spanish GBS Epidemiology Study Group (2016) Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge. BMC Neurol 16:75 Alcalde-Cabero E, Almazán-Isla J, García López FJ, Ara-Callizo JR, Avellanal F, Casasnovas C, Cemillán C, Cuadrado JI, Duarte J, Fernández-Pérez MD, Fernández Ó, Merino JA, Montero RG, Montero D, Pardo J, Rodríguez-Rivera FJ, Ruiz-Tovar M, de Pedro-Cuesta J; Spanish GBS Epidemiology Study Group (2016) Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge. BMC Neurol 16:75
31.
Zurück zum Zitat Incecik F, Hergüner O M, Altunbasak S (2011) Guillain–Barré syndrome in children. Neurol Sci (2011) 32:381–385 Incecik F, Hergüner O M, Altunbasak S (2011) Guillain–Barré syndrome in children. Neurol Sci (2011) 32:381–385
32.
Zurück zum Zitat Guillain Barrè Study Group (2000) Guillain Barré syndrome: an Italian multicentre case-control study. Neurol Sci 21:229–234CrossRef Guillain Barrè Study Group (2000) Guillain Barré syndrome: an Italian multicentre case-control study. Neurol Sci 21:229–234CrossRef
33.
Zurück zum Zitat Tam CC, O’Brien SJ, Peterson I, Islam A, Hayward A, Rodrigues LC (2007) Guillain Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One 2(4):e344CrossRefPubMedPubMedCentral Tam CC, O’Brien SJ, Peterson I, Islam A, Hayward A, Rodrigues LC (2007) Guillain Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. PLoS One 2(4):e344CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Webb AJ, Brain SA, Wood R, Rinaldi S, Turner MR (2015) Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry 86:1196–1201CrossRefPubMed Webb AJ, Brain SA, Wood R, Rinaldi S, Turner MR (2015) Seasonal variation in Guillain-Barré syndrome: a systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry 86:1196–1201CrossRefPubMed
35.
Zurück zum Zitat Galeotti F, Massari M, D’Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R, The ITANG study group (2013) Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination. Eur J Epidemiol 28:433–444CrossRefPubMedPubMedCentral Galeotti F, Massari M, D’Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R, The ITANG study group (2013) Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination. Eur J Epidemiol 28:433–444CrossRefPubMedPubMedCentral
Metadaten
Titel
Incidence study of Guillain-Barré syndrome in the province of Ferrara, Northern Italy, between 2003 and 2017. A 40-year follow-up
verfasst von
Enrico Granieri
Nico Golfrè Andreasi
Paolo De Martin
Vittorio Govoni
Massimiliano Castellazzi
Edward Cesnik
Maura Pugliatti
Ilaria Casetta
Publikationsdatum
01.03.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 3/2019
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-018-3688-4

Weitere Artikel der Ausgabe 3/2019

Neurological Sciences 3/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.